Dr. Kasthuri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Univ Of North Carolina Hospi Dr
# 101
Chapel Hill, NC 27599Phone+1 919-966-3311Fax+1 919-843-4896
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2002 - 2005
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1999 - 2002
- Kasturba Med College MangaloreClass of 1997
Certifications & Licensure
- NC State Medical License 2007 - 2025
- MN State Medical License 2002 - 2008
- IL State Medical License 1999 - 2002
Clinical Trials
- Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium Falciparum Start of enrollment: 2009 Nov 01
- Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Start of enrollment: 2010 Apr 08
- Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia Start of enrollment: 2023 Jul 01
Publications & Presentations
PubMed
- Potential and emerging therapeutics for HHT.Harish Eswaran, Raj S Kasthuri
Hematology. American Society of Hematology. Education Program. 2024-12-06 - Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era.Ayotola A Fatola, Michael D Evans, Jenna Brown, Elizabeth Davis, Andrew David Johnson
Blood Advances. 2024-12-03 - Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.Hanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, Allyson M Pishko, Jake E Decker
The New England Journal of Medicine. 2024-09-19
Abstracts/Posters
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraRaj S. Kasthuri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bl...Raj S. Kasthuri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian PopulationsRaj S. Kasthuri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Evaluating the Accuracy of the Curacao Criteria in Diagnosing HHT in ChildrenApril 11th, 2018
- Department of Pharmacy Earns $50,000 Award for Excellence in Medication SafetyDecember 7th, 2017
- Prevalence and Predictors of Anemia in Hereditary Hemorrhagic TelangiectasiaJune 22nd, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: